Prestige Consumer Healthcare Net Profit Margin 2012-2026 | PBH
Prestige Consumer Healthcare net profit margin from 2012 to 2026. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Prestige Consumer Healthcare Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2026-03-31 | $1.09B | $0.19B | 17.45% |
| 2025-12-31 | $1.10B | $0.19B | 16.85% |
| 2025-09-30 | $1.11B | $0.20B | 18.00% |
| 2025-06-30 | $1.12B | $0.21B | 18.91% |
| 2025-03-31 | $1.14B | $0.21B | 18.80% |
| 2024-12-31 | $1.12B | $0.21B | 19.05% |
| 2024-09-30 | $1.11B | $0.21B | 18.45% |
| 2024-06-30 | $1.11B | $0.21B | 18.42% |
| 2024-03-31 | $1.13B | $0.21B | 18.58% |
| 2023-12-31 | $1.13B | $-0.08B | -7.14% |
| 2023-09-30 | $1.13B | $-0.08B | -7.28% |
| 2023-06-30 | $1.13B | $-0.09B | -7.52% |
| 2023-03-31 | $1.13B | $-0.08B | -7.36% |
| 2022-12-31 | $1.11B | $0.21B | 18.94% |
| 2022-09-30 | $1.11B | $0.21B | 18.79% |
| 2022-06-30 | $1.09B | $0.20B | 18.46% |
| 2022-03-31 | $1.09B | $0.21B | 18.88% |
| 2021-12-31 | $1.06B | $0.19B | 17.88% |
| 2021-09-30 | $1.02B | $0.18B | 17.61% |
| 2021-06-30 | $0.98B | $0.18B | 18.31% |
| 2021-03-31 | $0.94B | $0.17B | 17.60% |
| 2020-12-31 | $0.96B | $0.17B | 17.47% |
| 2020-09-30 | $0.96B | $0.16B | 17.10% |
| 2020-06-30 | $0.96B | $0.15B | 15.83% |
| 2020-03-31 | $0.96B | $0.14B | 14.75% |
| 2019-12-31 | $0.95B | $-0.03B | -3.57% |
| 2019-09-30 | $0.95B | $-0.03B | -3.57% |
| 2019-06-30 | $0.95B | $-0.04B | -3.78% |
| 2019-03-31 | $0.98B | $-0.04B | -3.69% |
| 2018-12-31 | $0.99B | $0.06B | 6.36% |
| 2018-09-30 | $1.02B | $0.34B | 33.33% |
| 2018-06-30 | $1.04B | $0.34B | 32.72% |
| 2018-03-31 | $1.04B | $0.34B | 32.63% |
| 2017-12-31 | $1.03B | $0.39B | 38.07% |
| 2017-09-30 | $0.97B | $0.11B | 11.10% |
| 2017-06-30 | $0.93B | $0.11B | 11.72% |
| 2017-03-31 | $0.88B | $0.07B | 7.81% |
| 2016-12-31 | $0.85B | $0.07B | 8.47% |
| 2016-09-30 | $0.83B | $0.07B | 8.16% |
| 2016-06-30 | $0.82B | $0.07B | 8.25% |
| 2016-03-31 | $0.81B | $0.10B | 12.41% |
| 2015-12-31 | $0.79B | $0.11B | 13.96% |
| 2015-09-30 | $0.79B | $0.10B | 13.10% |
| 2015-06-30 | $0.76B | $0.09B | 11.43% |
| 2015-03-31 | $0.72B | $0.08B | 10.91% |
| 2014-12-31 | $0.67B | $0.07B | 10.48% |
| 2014-09-30 | $0.62B | $0.05B | 8.46% |
| 2014-06-30 | $0.60B | $0.07B | 11.48% |
| 2014-03-31 | $0.60B | $0.07B | 12.21% |
| 2013-12-31 | $0.61B | $0.08B | 12.54% |
| 2013-09-30 | $0.62B | $0.09B | 13.69% |
| 2013-06-30 | $0.62B | $0.07B | 11.53% |
| 2013-03-31 | $0.62B | $0.07B | 10.48% |
| 2012-12-31 | $0.60B | $0.05B | 7.63% |
| 2012-09-30 | $0.55B | $0.04B | 8.01% |
| 2012-06-30 | $0.49B | $0.04B | 7.71% |
| 2012-03-31 | $0.44B | $0.04B | 8.62% |
| 2011-12-31 | $0.40B | $0.04B | 10.92% |
| 2011-09-30 | $0.39B | $0.04B | 9.28% |
| 2011-06-30 | $0.36B | $0.03B | 9.44% |
| 2011-03-31 | $0.34B | $0.03B | 8.63% |
| 2010-12-31 | $0.31B | $0.03B | 8.47% |
| 2010-09-30 | $0.29B | $0.04B | 12.07% |
| 2010-06-30 | $0.29B | $0.03B | 11.60% |
| 2010-03-31 | $0.29B | $0.03B | 10.92% |
| 2009-12-31 | $0.28B | $-0.18B | -64.31% |
| 2009-09-30 | $0.29B | $-0.19B | -64.46% |
| 2009-06-30 | $0.29B | $-0.19B | -63.70% |
| 2009-03-31 | $0.30B | $-0.19B | -63.05% |
| 2008-12-31 | $0.31B | $0.04B | 11.40% |
| 2008-09-30 | $0.31B | $0.04B | 11.33% |
| 2008-06-30 | $0.31B | $0.03B | 10.65% |
| 2008-03-31 | $0.32B | $0.03B | 10.48% |
| 2007-12-31 | $0.32B | $0.03B | 9.57% |
| 2007-09-30 | $0.32B | $0.03B | 10.49% |
| 2007-06-30 | $0.32B | $0.04B | 11.18% |
| 2007-03-31 | $0.32B | $0.04B | 11.29% |
| 2006-12-31 | $0.32B | $0.03B | 9.97% |
| 2006-09-30 | $0.32B | $0.03B | 9.35% |
| 2006-06-30 | $0.31B | $0.03B | 9.06% |
| 2006-03-31 | $0.30B | $0.03B | 8.78% |
| 2005-12-31 | $0.29B | $0.02B | 7.48% |
| 2005-09-30 | $0.29B | $0.02B | 6.27% |
| 2005-06-30 | $0.29B | $0.02B | 5.78% |
| 2005-03-31 | $0.30B | $0.00B | 0.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $2.676B | $1.138B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $174.688B | 19.48 |
| Stryker (SYK) | United States | $129.889B | 24.88 |
| Medtronic (MDT) | Ireland | $111.968B | 15.57 |
| EssilorLuxottica (ESLOY) | France | $107.724B | 0.00 |
| Boston Scientific (BSX) | United States | $91.831B | 20.26 |
| Medline (MDLN) | United States | $59.904B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.712B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $33.391B | 15.98 |
| ResMed (RMD) | United States | $33.341B | 22.26 |
| Agilent Technologies (A) | United States | $32.516B | 20.44 |
| Koninklijke Philips (PHG) | Netherlands | $27.260B | 16.18 |
| Terumo (TRUMY) | Japan | $19.854B | 23.21 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.025B | 11.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.227B | 0.00 |
| Insulet (PODD) | United States | $13.640B | 39.54 |
| Baxter (BAX) | United States | $8.854B | 7.56 |
| Sunny Optical Technology (SNPTF) | China | $8.381B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.537B | 28.15 |
| Demant (WILYY) | Denmark | $6.395B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.247B | 15.90 |
| Envista Holdings (NVST) | United States | $4.301B | 21.99 |
| BillionToOne (BLLN) | United States | $3.729B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $3.666B | 0.00 |
| ICU Medical (ICUI) | United States | $3.141B | 20.47 |
| Haemonetics (HAE) | United States | $2.664B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $2.611B | 48.16 |
| Phibro Animal Health (PAHC) | United States | $2.347B | 20.67 |
| GN Store Nord (GNNDY) | Denmark | $2.270B | 21.90 |
| Neogen (NEOG) | United States | $2.050B | 44.86 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.028B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.794B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.654B | 32.89 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.495B | 3.96 |
| AtriCure (ATRC) | United States | $1.429B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.386B | 15.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.043B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.953B | 164.50 |
| QuidelOrtho (QDEL) | United States | $0.943B | 6.53 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.896B | 0.00 |
| InMode (INMD) | Israel | $0.857B | 9.40 |
| Omeros (OMER) | United States | $0.827B | 6.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.789B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.766B | 0.00 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Brainsway (BWAY) | Israel | $0.546B | 55.68 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 11.18 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.367B | 25.70 |
| SNDL (SNDL) | Canada | $0.366B | 0.00 |
| Cerus (CERS) | United States | $0.363B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.311B | 126.00 |
| Evolus (EOLS) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Accendra Health (ACH) | United States | $0.215B | 2.96 |
| Utah Medical Products (UTMD) | United States | $0.210B | 18.94 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.194B | 57.17 |
| TerrAscend (TSNDF) | Canada | $0.193B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Quanterix (QTRX) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.152B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.143B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.73 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.064B | 0.00 |
| Biote (BTMD) | United States | $0.063B | 3.46 |
| INLIF (INLF) | China | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 26.91 |
| United-Guardian (UG) | United States | $0.030B | 14.23 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |